A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

CoLink Vallux Active Bunion Launches Reports In2Bones Global

Multi-directional, No Fusion Correction Speeds and Simplifies Bunion Surgeries

The Active Bunion implant and guided translational osteotomy technique improve on traditional open fixation approaches as well as newer bunion surgeries by providing surgeons with a simpler, faster procedure that doesn’t violate the joint or require a 1st Tarsometatarsal joint fusion.

The implant consists of a zero-prominence CoLink Vallux™ plate and a choice of non-locking and variable angle locking screws for enhanced angular stability, together with a full instrument set.

Using this new, minimally invasive procedure, surgeons can correct joint alignment in multiple dimensions while avoiding any restriction of the joint space and not fusing the joint at the midfoot. The result is total range of motion preservation and superior cosmesis via a much smaller incision of 1-2 cm, compared with the larger incision required for Chevron osteotomy (5-7 cm).

For the patient, the Active Bunion’s smaller incision and technique as a whole reduces internal scarring compared with other bunion corrections, decreasing the typical postoperative stiffness, pain, and potential for wound complications.

“Patients prefer the smallest possible incision, and they do not want a fused joint unless absolutely necessary,” explains Jon Simon, Executvie Vice President of Commerical at In2Bones. “The CoLink Vallux Active Bunion fulfills both of these patient demands.”

An Evolved Surgery with More Surgeon and Patient Benefits

With greater simplicity comes shorter OR time. The Active Bunion procedure can typically be completed in about 20 minutes, compared to 40-60 minutes plus for other more invasive and complex corrections. Recovery can also be shorter than traditional bunion surgeries. With no joint violation, which preserves the total range of motion, patients may return to weight-bearing activity sooner, with less physical therapy.

The Active Bunion’s evolved technique, technology, and fixation solution is intended to address over 90 percent of bunion cases. Compare it to other established hallux valgus procedures:

Lapidus – Unlike this end-stage procedure, the Active Bunion’s simpler, quicker guided implant technique cuts down on multiple surgical steps, thereby decreasing OR time. It spares the midfoot joint from fusion, with early weight-bearing, improved cosmesis, and fewer overall complications.

Percutaneous Screw Fixation – Compared to the blind resection and steep learning curve required for the Burr osteotomy, the Active Bunion procedure is reproducible and straightforward. The guided osteotomy reduces the risk of shortening or necrosis.

IM Blade Plates – Eliminating multiple surgical steps common to this technique, the Active Bunion procedure allows surgeons to dictate placement while the implant provides greater strength and stability through two distal and proximal screws instead of the customary single screw.

Like all other products in In2Bones’ extensive platform of single-use implants for the hand and foot, the CoLink Vallux™ Active Bunion system is packaged sterile for traceability and patient safety.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy